Saks, Nordstrom, Ma...
Health Care: Drugs
Cambrex Corporation (CBM: NYSE)
$12.89 -0.13 | -1.00%
05/21/13 - 04:04 PM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | 62.30M | 10.97M | 9.65M | 10.39M |
| Operating Gains/Losses | 1.77M | 1.62M | 1.16M | 0.00 |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | -6.31M | 2.07M | -7.15M | 5.93M |
| (Increase) Decrease in Inventories | -10.30M | -3.52M | -4.92M | 712.00K |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | 3.13M | 4.66M | -938.00K | -13.04M |
| (Decrease) Increase In Other Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Working Capital | 10.69M | -6.25M | -374.00K | -2.36M |
| Other Non-Cash Items | 5.13M | 5.66M | 4.32M | 10.45M |
| Net Cash From Continuing Operations | 47.29M | 38.32M | 23.76M | 34.39M |
| Net Cash From Discontinued Operations | -3.75M | 0.00 | -471.00K | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | 43.55M | 38.32M | 23.28M | 34.39M |
| Sale of Property, Plant & Equipment | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Property, Plant & Equipment | -18.16M | -15.01M | -12.64M | -12.59M |
| Acquisitions | 0.00 | -500.00K | -25.25M | 0.00 |
| Purchases of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Cash from Investing Activities | -2.03M | 20.00K | -18.00K | 67.00K |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -20.18M | -15.49M | -39.05M | -12.52M |
| Issuance of Debt | 5.50M | 105.80M | 33.20M | 23.60M |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 1.36M | 145.00K | 0.00 | 9.00K |
| Repayment of Long-Term Debt | -39.50M | -123.70M | -38.10M | -26.60M |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | -889.00K |
| Other Financing Charges, Net | -22.00K | -1.88M | -54.00K | -48.00K |
| Net Cash From Financing Activities | -32.67M | -19.64M | -4.95M | -3.93M |
| Effect of Exchange Rate Changes | 933.00K | -891.00K | -2.03M | 1.88M |
| Net Change in Cash & Cash Equivalents | -8.37M | 2.31M | -22.75M | 19.82M |
Portfolios with CBM
- Portfolio NameUser Type
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks At New 52-Week Highs...
- UserSUPRATRADE HOT STOCKS (BUY ...
- UserPART 2 JPMorgan 28th Annual...
- UserPART 3 JPMorgan 27th Annual...
- UserRocket Stocks For The Week ...
- UserValue Seeker
- UserPART 3 JPMorgan 26th Annual...
Latest CBM Headlines from TheStreet
- January 2014 Options Now Available For Cambrex (CBM) 05.20.13 | 02:05 pm
- A Lower Stock Price Never Turns A Bad Company Into A Good One 03.27.13 | 06:03 am
- NYSE Stocks Posting Largest Percentage Decreases 11.06.12 | 06:11 pm
- NYSE Stocks Posting Largest Percentage Decreases 11.06.12 | 01:11 pm
- 5 Stocks Poised for Breakouts 10.12.12 | 01:10 pm
- 8 Stocks Soaring Higher With Big Volume 09.21.12 | 02:09 pm
- Cambrex Stock Gaps Up On Today's Open (CBM) 05.04.12 | 09:05 am
- Cambrex Corporation Stock Upgraded (CBM) 02.08.12 | 06:02 am
- NYSE Stocks Posting Largest Percentage Decreases 02.07.12 | 06:02 pm
- NYSE Stocks Posting Largest Percentage Decreases 02.07.12 | 01:02 pm
Press Releases for CBM
- Cambrex To Present At UBS Global Healthcare Conference - PR Newswire 05.13.13 | 01:05 pm
- Cambrex To Present At The 12th Annual Needham Healthcare Conference - PR Newswire 04.23.13 | 09:04 am
- Dow Chemical And Cambrex Collaborate To Manufacture Drug-Solubility Solution - PR Newswire 02.14.13 | 09:02 am
- Cambrex Corporation Announces Appointment Of Shlomo Yanai As Vice Chairman Of The Board Of Directors - PR Newswire 11.29.12 | 08:11 am
- Cambrex Announces Significant New Supply Agreement - PR Newswire 08.14.12 | 04:08 pm
- Cambrex To Present At UBS 22nd Annual Global Healthcare Services Conference - PR Newswire 02.06.12 | 03:02 pm
- Cambrex And Tillotts Enter A Development And Commercialization Agreement For Proprietary 5-ASA-Based Technology - PR Newswire 07.06.11 | 08:07 am
- Cambrex Zenara Manufacturing Facility Receives European GMP Approval - PR Newswire 01.18.11 | 09:01 am
- Shawn P. Cavanagh Appointed Chief Operating Officer Of Cambrex - PR Newswire 01.07.11 | 01:01 pm
- Cambrex Zenara Supplies Product For Launch Of Nicorette® In India - PR Newswire 01.06.11 | 03:01 pm
Partner Headlines for CBM
- Sally Beauty, Lithia: Hennessy Buys, Holds A Year - Investor's Business Daily 11.05.12 | 05:11 pm
- Cambrex Corporation - Aggressive Growth - Zacks 10.04.12 | 01:10 am
- Zacks #1 Rank Additions for Tuesday - Tale of the Tape - NASDAQ 09.04.12 | 01:09 pm
- Zacks #1 Rank Additions for Tuesday - Tale of the Tape - Zacks 09.04.12 | 09:09 am
- Zacks #1 Rank Additions for Wednesday - Tale of the Tape - NASDAQ 08.22.12 | 12:08 pm
- Zacks #1 Rank Additions for Wednesday - Tale of the Tape - Zacks 08.22.12 | 09:08 am
- Cambrex Signs New Supply Agreement - Analyst Blog - NASDAQ 08.17.12 | 08:08 pm
- Cambrex Corp. - Momentum - NASDAQ 08.16.12 | 05:08 am
- Cambrex Corp. - Momentum - Zacks 08.16.12 | 01:08 am
- Zacks #1 Rank Additions for Tuesday - Tale of the Tape - Zacks 08.14.12 | 09:08 am
